Crizotinib vs. pemetrexed or docetaxel in advanced ALK+ non-small cell lung cancer: Subgroup analysis in PROFILE 1007 Meeting Abstract
| Authors: | Yamamoto, N.; Nokihara, H.; Han, J. Y.; Hida, T.; Riely, G. J.; Baldini, E.; Salvatore, S.; Horn, L.; Polli, A.; Satouchi, M. |
| Abstract Title: | Crizotinib vs. pemetrexed or docetaxel in advanced ALK+ non-small cell lung cancer: Subgroup analysis in PROFILE 1007 |
| Meeting Title: | 11th Annual Meeting of the Japanese Society of Medical Oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 24 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2013 Aug 29-31 |
| Meeting Location: | Sendai, Japan |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2013-11-01 |
| Start Page: | ix43 |
| Language: | English |
| ACCESSION: | WOS:000327511100103 |
| DOI: | 10.1093/annonc/mdt459.55 |
| PROVIDER: | wos |
| PUBMED: | 24288781 |
| Notes: | Meeting Abstract: O1-133 -- Oral Session -- Source: Wos |
